Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Completed · Not applicable

Conditions studied: Breast Cancer, Ovarian Cancer

In brief

GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) with NIH permission.

Key facts

Study ID

NCT03326713

Run by

Rutgers, The State University of New Jersey

People needed

668

Starts

2017-11-02

Expected to finish

2022-06-02

Last updated by the study team

2026-06-25

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Breast Cancer
• Hispanic or non-Hispanic
• Female
• 21 years of age or older
• English-speaking
• Breast cancer history
• breast cancer at the age of 50 or younger OR
• triple-negative breast cancer OR
• two or more primary breast cancers
• Ovarian Cancer
• Hispanic or non-Hispanic
• Female
• 21 years of age or older
• English-speaking
• History of ovarian, fallopian, or peritoneal cancer diagnosed at any age

You may not qualify if…

• Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer

Where it is running

• Rutgers University — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.